Tumor Necrosis Factor Receptor Superfamily Member 4 - Pipeline Review, H1 2016 - New Market Report
Global Markets Direct's, 'Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016', provides in depth analysis on Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) targeted pipeline therapeutics.
View full press release